CannTrust Holdings Inc. – Taking Top Pick Target Up

CannTrust Holdings Inc. – Taking Top Pick Target Up

CannTrust Holdings Inc. View Report (PDF)opens in a new window​​ TRST-CSE: $6.83 | SPECULATIVE BUY​​ 12-Month Target Price: $15.00 ​​ Projected Return: 120% | Valuation: 13.0x F2019 EV/EBITDA Russell Stanley |​​ rstanley@echelonpartners.comopens in a new...

CANNTRUST

Since 2013 CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions | Accessibility

Pin It on Pinterest